Waning effectiveness against COVID-19-related hospitalization, severe complications, and mortality with two to three doses of CoronaVac and BNT162b2: a case–control study

Background: This study aims to evaluate waning effectiveness against severe and fatal COVID-19 with two to three doses of CoronaVac/BNT162b2, where data are limited. Methods: A case–control study included individuals aged ≥18 years, unvaccinated or received two to three doses of CoronaVac/BNT162b2,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Vincent Ka Chun, Wan, Eric Yuk Fai, Ye, Xuxiao, Mok, Anna Hoi Ying, Lai, Francisco Tsz Tsun, Chui, Celine Sze Ling, Li, Xue, Wong, Carlos King Ho, Li, Philip Hei, Ma, Tiantian, Qin, Simon, Lau, Chak Sing, Wong, Ian Chi Kei, Chan, Esther Wai Yin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Coronaviruses
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197998/
https://www.ncbi.nlm.nih.gov/pubmed/37132361
http://dx.doi.org/10.1080/22221751.2023.2209201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197998/
https://www.ncbi.nlm.nih.gov/pubmed/37132361
http://dx.doi.org/10.1080/22221751.2023.2209201

Ejemplares similares